logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Sigilon Therapeutics, Inc.


USPTO Granted Patents = 10


Trademarks = 2

Forward Citations = 0

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Richard Heidebrecht (7 out of 7 patents)

silverMedal Robert James Miller (7 out of 7 patents)

bronzeMedal Omid Veiseh (5 out of 27 patents)

4.  Lauren Emily Barney (4 out of 4 patents)

5.  Erika Ellen Johnston (4 out of 4 patents)

6.  Matthias Alexander Oberli (4 out of 4 patents)

7.  Paul Kevin Wotton (4 out of 4 patents)

8.  David Peritt (3 out of 4 patents)

9.  Michael Beauregard (3 out of 3 patents)

10.  Jared A Sewell (3 out of 3 patents)

11.  Marianthi Papakosta (2 out of 2 patents)

12.  Guillaume Carmona (2 out of 2 patents)

13.  Francisco Caballero Gonzalez (2 out of 2 patents)

14.  Jeffrey Charles Way (1 out of 32 patents)

15.  Guillaume Carmona (1 out of 1 patent)


10 patents:

1. 12674791 - Methods of evaluating small molecule-modified polymers in compositions (2026-07-07),
2. 12653888 - COMPOSITIONS, DEVICES AND METHODS FOR INDUCING IMMUNE RESPONSES TO INFECTIOUS AGENTS (2026-06-16),
3. 12649930 - COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE (2026-06-09),
4. 12605486 - Afibrotic compounds, devices, and uses thereof (2026-04-21),
5. 12570955 - MONOCLONAL CELL LINES EXPRESSING AN EXOGENOUS SUBSTANCE AND USES THEREOF (2026-03-10),
6. 12522571 - Compounds, devices, and uses thereof (2026-01-13),
7. 12306081 - Apparatuses and methods for formation of particles (2025-05-20),
8. 12162994 - Biocompatible hydrogel capsules and process for preparing same (2024-12-10),
9. 12161760 - Implantable particles and related methods (2024-12-10),
10. 11945786 - Compounds, devices, and uses thereof (2024-04-02),
Company Overview
Sigilon Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapies for chronic diseases. The company focuses on creating cell-based therapies that leverage its proprietary platform to encapsulate and protect therapeutic cells, enabling sustained delivery of biologics. Sigilon's research primarily targets conditions such as hemophilia and other rare diseases, aiming to improve patient outcomes through advanced therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,866 in US

#56,047 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Sigilon Therapeutics, Inc.

Forward Citations = 0

27 inventors:

goldMedal Richard Heidebrecht (7 out of 7 patents)

silverMedal Robert James Miller (7 out of 7 patents)

bronzeMedal Omid Veiseh (5 out of 27 patents)

4.  Lauren Emily Barney (4 out of 4 patents)

5.  Erika Ellen Johnston (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sigilon Therapeutics, Inc.. Retrieved from https://idiyas.com/company/sigilon-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…